Microsoft Word - RadBio_Programme_ParisSept2017_verAug31

Previous Page

Next Page

Page Background

control

drug X

XRT

drug + XRT

Human s.c.c. xenograft treated with 8 X 3 Gy / 4 wks

drug X = VEGFR2 inhibitor

Tumor removed

Tumor regression ≠ cell survival